SciSparc Granted FDA Approval for Phase IIb Trial of Novel Tourette Syndrome Therapy
Oct 1, 2024
Fda Invest Information
FDA Removes Clinical Hold on BMF-219 Trials for Diabetes by Biomea Fusion
Sep 27, 2024
InspireMD Seeks FDA Approval for CGuard Prime EPS Amidst Stock Volatility
Sep 18, 2024
Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition
Aug 30, 2024
Inspire Medical Systems Achieves FDA Approval for Pioneering Inspire V Therapy System
Aug 6, 2024
FDA Grants Anixa Biosciences' Individual Patient IND for Second Dose of CAR-T Ovarian Cancer Therapy
Jul 23, 2024
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients
Jul 10, 2024
FDA Approves Lilly's Kisunla™ for Early Symptomatic Alzheimer's
Jul 3, 2024
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Eisai Submits LEQEMBI® (lecanemab-irmb) Biologics License Update to FDA for Early Alzheimer's Treatment – Biogen Stocks in Focus
Jun 10, 2024
Sobi's Emapalumab-lzsg Granted FDA Fast Track Designation for Macrophage Activation Syndrome
May 25, 2024
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP
May 14, 2024
Meta Platforms, Inc. Under Investigation by U.S. Prosecutors for Alleged Role in Illicit Drug Sales
Mar 16, 2024
Quoin Pharmaceuticals Gains FDA Approval to Include Teens in Netherton Syndrome Studies, Boosting QNRX Shares
Mar 5, 2024
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment
Mar 5, 2024
Intelligent Bio Solutions Forges Strategic Alliance with Cliantha Research for Vital FDA 510(k) Clinical Study
Feb 28, 2024
FDA Approves Asthma Drug Xolair for Treating Severe Food Allergies
Feb 17, 2024
Inhibikase Therapeutics Reports Preliminary FDA Meeting Outcomes for IkT-001Pro
Feb 8, 2024
Inhibikase Therapeutics Provides Update on FDA Pre-NDA Meeting for Cancer Treatment
Feb 8, 2024
Coherus BioSciences and Ascent Industries Highlight Stocks to Watch as Market Futures Dip
Dec 28, 2023
ReShape Lifesciences Soars on FDA Approval, Premarket Stock Movements Observed Across Various Sectors
Dec 14, 2023
Sernova Granted FDA Orphan Drug and Rare Pediatric Disease Designations for Hemophilia A Treatment
Nov 28, 2023
FDA Greenlights Immix Biopharma's IND for CAR-T Therapy NXC-201, Paving the Way for US Clinical Trials
Nov 21, 2023
Agilent (A) Secures FDA Nod for PD-L1 IHC 22C3, Aiding Cancer Treatment
Nov 16, 2023
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication
Nov 11, 2023
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva
Nov 10, 2023
The daily business briefing: November 9, 2023
Nov 10, 2023
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises
Nov 10, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression
Nov 9, 2023